An interventional study of heart rate variability biofeedback in Autonomic Dysfunction, Inflammatory Response and Chronic Kidney Diseases, sponsored by National Defense Medical Center, Taiwan. Status unknown at 1 site in Taiwan. Open to participants aged 20 Years and older. Per ClinicalTrials.gov, last updated 2023-03-23.
Sponsored by National Defense Medical Center, Taiwan · Not applicable, Interventional, and Supportive care
The prevalence and incidence of end-stage renal disease in Taiwan ranks highest in the world, and it is based on the 2018 health welfare According to statistics from the Ministry of Foreign Affairs, kidney disease is the ninth leading cause of death in Taiwan. As the course of chronic kidney disease (CKD) progresses, autonomic nervous system dysfunction, inflammation, and physical and psychological symptoms (such as fatigue, sleep disturbance, and depression) will increase, which will further damage the structure and function of the kidney Intensified, increasing the demand for dialysis treatment and the risk of cardiovascular disease, which consumes social and medical costs. If the investigators can intervene in a feasible measure to effectively regulate the autonomic nervous function of CKD patients, reduce inflammation and physical and psychological symptoms, and delay the progression of the disease, it will be the main goal of caring for CKD patients. To explore the intervention of heart rate variability biofeedback, which can improve the autonomic nervous function (heart rate variability [Heart Rate Variability]), inflammatory response (interleukin-6 [Interleukin-6, IL-6], C-reactive protein [ C reaction protein, CRP]) and physical and psychological symptoms (such as reducing fatigue, sleep disturbance and depression).
This study adopts an experimental research design and convenient sampling method. It is accepted in the nephrology clinic of a northern medical center in Taiwan. It is estimated that 80 patients will be enrolled. After the patients have signed the consent form, use the sealed envelope website (http://www.sealedenvelope.com) will randomly assigned to the experimental group and the control group. The experimental group receive HRV biofeedback for four consecutive weeks, combined with eight-week StressEraser home practice; the control group received general routine care. Both groups of cases were repeated three times on the day of acceptance, one month and three months after the case were accepted, a total of three repeated measurements of physiological indicators (HRV, IL-6, CRP) and symptom scales (Piper Fatigue Scale, Chinese version of Pittsburgh Sleep Quality Table, the second edition of the Chinese version of the Baker Depression Scale) to evaluate the effectiveness of HRV biofeedback. The research results will be statistically analyzed with SPSS version 23.0, and with descriptive statistics, the distribution of basic demographic data and the measurement results of various indicators will be analyzed. Paired-sample t-test, independent-sample t-test, and multivariate analysis of variance (MANOVA) were used to analyze the statistical results of intervention effectiveness inference; the significance level was set to 0.05.
166 studies on the registry are indexed under Autonomic Nervous System Diseases; 36 are open to participants now.
This study's planned enrollment of 80 is above the median of 40 across 107 interventional studies indexed under Autonomic Nervous System Diseases.
Browse Autonomic Nervous System Diseases studies →National Defense Medical Center, Taiwan is the lead sponsor of 63 studies on the registry; 17 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
HRV biofeedback
Behavioral: heart rate variability biofeedback
routine care
Heart rate variability biological feedback training is carried out in the outpatient meeting room of the hospital, including once a week, 30 minutes of hospital training each time, using Medea physiological feedback device portable Bluetooth physiological signal Feedback system (Medical Device Input No. 027390). Designed as two stages, stage one (the first week) first teaches the subject how to perform abdominal breathing, and connects the physiological feedback device to monitor the patient's breathing and heart rate changes, and sets the breath per minute according to the subject's resonance frequency . Stage two (second-four weeks) guide the case to understand the resonance relationship between breathing and heart rate, and then achieve the effect of matching heart and breath. It is also equipped with a pressure relief device (Helico Inc., New York, NY, USA) for self-practice at home.
autonomic nerve function
heart rate variability index
Time frame: baseline
autonomic nerve function
heart rate variability index
Time frame: 1 month
autonomic nerve function
heart rate variability index
Time frame: 3 month
inflammatory response 1
C reaction protein, CRP(ng/ml)
Time frame: baseline
inflammatory response 2
Interleukin-6, IL-6(pg/ml)
Time frame: baseline
inflammatory response 1
C reaction protein, CRP(ng/ml)
Time frame: 1 month
inflammatory response 2
Interleukin-6, IL-6(pg/ml)
Time frame: 1 month
inflammatory response 1
C reaction protein, CRP(ng/ml)
Time frame: 3 month
inflammatory response 2
Interleukin-6, IL-6(pg/ml)
Time frame: 3 month
symptom distress(fatigue)
Piper fatigue scale(Chinese version): Likert's four-point quantitative scale is scored, calculated on a scale of 0-3, with a total score of 0-48. The higher the score, the more serious the fatigue.
Time frame: baseline
symptom distress(sleep)
Pittsburgh Sleep Quality Index
Time frame: baseline
symptom distress(depression)
Beck Depression Inventory-II
Time frame: baseline
symptom distress(fatigue)
Piper fatigue scale(Chinese version): Likert's four-point quantitative scale is scored, calculated on a scale of 0-3, with a total score of 0-48. The higher the score, the more serious the fatigue.
Time frame: 1 month
symptom distress(sleep)
Pittsburgh Sleep Quality Index
Time frame: 1 month
symptom distress(depression)
Beck Depression Inventory-II
Time frame: 1 month
symptom distress(fatigue)
Piper fatigue scale(Chinese version): Likert's four-point quantitative scale is scored, calculated on a scale of 0-3, with a total score of 0-48. The higher the score, the more serious the fatigue.
Time frame: 3 month
symptom distress(sleep)
Pittsburgh Sleep Quality Index
Time frame: 3 month
symptom distress(depression)
Beck Depression Inventory-II
Time frame: 3 month
Plan to share: No
No publications or documents are linked to this record.
This study is status unknown, as verified in Mar 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Autonomic Nervous System Diseases→
National Defense Medical Center, Taiwan